Madrigal Pharmaceuticals (1MDGL.MI) Q1 2026 Earnings

19FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-4.42
-3.2
-1.98
-0.76

Details

Expected EPS
-0.7602712782000001
Actual EPS
-2.1827010000000002
Surprise EPS
-1.42
Surprise Percent
+187.1%

Description

Madrigal Pharmaceuticals (1MDGL.MI) has reported earnings of -2.1827010000000002 per share for Q1 2026.

0 Comments

Share your thoughts